Sumitomo Mitsui Trust Group
PCVX icon

Sumitomo Mitsui Trust Group’s Vaxcyte PCVX Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$426K Sell
7,331
-953
-12% -$51.7K ﹤0.01% 950
2025
Q4 		$382K Sell
8,284
-62
-0.7% -$2.77K ﹤0.01% 985
2025
Q3 		$301K Buy
+8,346
New +$277K ﹤0.01% 1014
2025
Q1 		– Sell
-5,363
Closed -$439K – 1057
2024
Q4 		$439K Sell
5,363
-286
-5% -$28.4K ﹤0.01% 967
2024
Q3 		$646K Buy
5,649
+1,120
+25% +$101K ﹤0.01% 938
2024
Q2 		$342K Buy
+4,529
New +$308K ﹤0.01% 1000

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group's PCVX Position: Q1 2026 in Review

Sumitomo Mitsui Trust Group reduced its Vaxcyte (PCVX) stake by 12% in Q1 2026, selling an estimated $51.7K and leaving 7,331 shares worth $426K. The position accounts for ﹤0.01% of the portfolio, ranked #950.

Sumitomo Mitsui Trust Group first reported a position in PCVX in Q2 2024 and has held it in 6 quarters since. The position peaked at $646K in Q3 2024. 336 funds tracked by Wall St. Rank hold PCVX as of Q1 2026.

  • Sumitomo Mitsui Trust Group held 7,331 shares of Vaxcyte worth $426K as of Q1 2026.
  • Sumitomo Mitsui Trust Group sold 953 Vaxcyte shares in Q1 2026, an estimated $51.7K.
  • Vaxcyte made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #950 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Vaxcyte in Q2 2024 and has held it in 6 quarters since.
  • Sumitomo Mitsui Trust Group's Vaxcyte position peaked at $646K in Q3 2024.
  • 336 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.